Atlas Trials

Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis

Clinical trial NCT02595073 · COMPLETED

Trial details

NCT number
NCT02595073
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2015-09-04
Primary completion
2017-01-17
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.